MTST (MetaStat) EBIT: $-3.06 Mil (TTM As of Feb. 2018)


What is MetaStat EBIT?

MetaStat MTST EBIT is $-3.06 Mil as of Feb. 2018.

MetaStat's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2018 was $-0.94 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2018 was $-3.06 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MetaStat's annualized ROC % for the quarter that ended in Feb. 2018 was -246.98%. MetaStat's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2018 was -1,030.92%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. MetaStat's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2018 was -51,016.67%.

MetaStat  (OTCPK:MTST) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MetaStat's annualized ROC % for the quarter that ended in Feb. 2018 is calculated as:

ROC % (Q: Feb. 2018 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2017 ) + Invested Capital (Q: Feb. 2018 ))/ count )
=-3.512 * ( 1 - 0% )/( (1.446 + 1.398)/ 2 )
=-3.512/1.422
=-246.98 %

where

Invested Capital(Q: Nov. 2017 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1.274 - 0.879 - ( 0.782 - max(0, 1.904 - 0.853+0.782))
=1.446

Invested Capital(Q: Feb. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.73 - 1.08 - ( 0.317 - max(0, 2.08 - 0.332+0.317))
=1.398

Note: The Operating Income data used here is four times the quarterly (Feb. 2018) data.

2. Joel Greenblatt's definition of Return on Capital:

MetaStat's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2018 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2018 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2017  Q: Feb. 2018
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.768/( ( (0.377 + max(-0.833, 0)) + (0.354 + max(-1.065, 0)) )/ 2 )
=-3.768/( ( 0.377 + 0.354 )/ 2 )
=-3.768/0.3655
=-1,030.92 %

where Working Capital is:

Working Capital(Q: Nov. 2017 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.071) - (0.879 + 0.025 + 0)
=-0.833

Working Capital(Q: Feb. 2018 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.015) - (1.08 + 0 + 0)
=-1.065

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2018) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MetaStat's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2018 )
=-3.061/0.006
=-51,016.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat EBIT Related Terms

MetaStat EBIT Historical Data

* Premium members only.

The historical data trend for MetaStat's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat EBIT Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.23 -7.36 -4.34 -1.88 -3.06

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 -0.25 -0.73 -1.14 -0.94

MTST vs OBMP, NSPX, ATRX: EBIT Comparison

For the Biotechnology subindustry, MetaStat's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MetaStat EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MetaStat's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MetaStat's EV-to-EBIT falls into.


MetaStat EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-3.06 Mil mean?
MetaStat (MTST) has a EBIT of $-3.06 Mil as of Feb. 2018. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MetaStat.
Is MetaStat's EBIT too high?
MetaStat's current EBIT is $-3.06 Mil.
How does MetaStat's EBIT compare to OBMP and NSPX?
MetaStat's EBIT of $-3.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MetaStat. MetaStat's current EBIT is $-3.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current EBIT of $-3.06 Mil. The current EBIT is $-3.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For MetaStat (MTST), the current EBIT is $-3.06 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.